EATG » Access

Access

South Africa: Providing healthcare to men who have sex with men is complex but possible

Research has shown that addressing HIV in certain key populations is a priority in order to end the epidemic in the general population. Key populations are groups identified by the…

Collective efforts by civil society groups bar the way to hepatitis C patents

Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position toward the high prices of medicines, as high-income countries were…

Will the European Court of Justice put a stop to the evergreening of Truvada patents?

Truvada, the fixed-dose combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is a critical medicine in both HIV treatment and prevention. It is used as pre-exposure prophylaxis (PrEP), which…

Truvada case shows civil society’s success with pre-grant opposition

The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to patents it felt were unjustified were rewarded by patent withdrawal…

Brazil rejects a key patent on Gilead hepatitis C drug and EU denies patent extension to Gilead’s HIV drug

Major win for patients as Brazil rejects a key patent on Gilead hepatitis C drug and European Union denies patent extension to Gilead's HIV drug Though more than 85% of…

Civil society key in TRIPS flexibility implementation

When the agreement on intellectual property was adopted by the World Trade Organization, a number of flexibilities were included in the text, mainly to give developing countries policy space to…

A patient has died from AIDS in Switzerland because he was not paid for HIV treatment

As it became known to the media, an HIV-positive patient died from AIDS in Switzerland in the end of 2017. He was being refused of a medical treatment due to…

South Africa tests ATMs for medicine

People living with HIV and other chronic illnesses are getting faster, simpler access to essential medicines thanks to new medicine dispensing machines being piloted in Johannesburg, South Africa. The non-profit…

MPP adds new suppliers from South Africa and South Korea to its growing generic manufacturing network

Twenty-five product developers now working with the MPP to manufacture low-cost, quality-assured treatments for developing countries Geneva, 02 May 2018 — The Medicines Patent Pool (MPP) today announced five new generic manufacturing…

Ukraine eyes patent law reform after civil society push on medicines access

Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups for better access to affordable medicines and healthcare. The All-Ukrainian…